Ładuje się......
Comparison of (123)I-Metaiodobenzylguanidine (MIBG) and (131)I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Children’s Oncology Group
BACKGROUND: (123)I-metaiodobenzylguanidine (MIBG) scans are preferable to (131)I-MIBG for neuroblastoma imaging as they deliver less patient radiation yet have greater sensitivity in disease detection. Both (123)I-MIBG and (131)I-MIBG scans were used for disease assessments of neuroblastoma patients...
Zapisane w:
| Wydane w: | Pediatr Blood Cancer |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2011
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581540/ https://ncbi.nlm.nih.gov/pubmed/21328522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22991 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|